Radius Health to Announce Second Quarter 2019 Financial Results, Host Conference Call and Live Webcast on Wednesday, August 7, 2019

NEXT STORY
Diabetes Treatment Devices Market to Reach US$ 16,706.4 Mn by 2026, Medtronic and a Few Leading Players Account for the Highest Share: Fortune Business Insights
PREV STORY
Ophthalmic Lasers Market to Register 5.3% CAGR; Novartis Announces its FDA Approval to Perform Advanced Ophthalmic Surgeries: Fortune Business Insights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sandoz receives European Commission approval for biosimilar Hyrimoz® (adalimumab)

Biosimilar Hyrimoz® (adalimumab) approved for use in all same indications as reference medicine*** including ...

author_avatar
NASDAQ Market News

Aduro Biotech Europe’s Hans van Eenennaam, Ph.D. and John Dulos, Ph.D. Honored with the Intellectual Property Owners Education Foundation’s 43rd Inventor of the Year Award for Contributions in the Discovery of KEYTRUDA® (pembrolizumab)

BERKELEY, Calif. and OSS, The Netherlands, Dec. 06, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, ...

author_avatar
NASDAQ Market News

Zai Lab Limited to present at the Leerink Partners 7th Annual Global Healthcare Conference

SHANGHAI, China, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based ...

author_avatar
NASDAQ Market News